Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
serum_biomarkers_for_neurodegeneration [2019/12/12 00:03] – [Related work] adminserum_biomarkers_for_neurodegeneration [2019/12/19 23:44] – [Analysis] admin
Line 12: Line 12:
 ===== Collaborators ===== ===== Collaborators =====
  
-Dr. Sudha Seshadri, the Founding director of the Glenn [[https://biggsinstitute.org/|Biggs]] Institute for Alzheimer's & Neurodegenerative Diseases, and Dr. Mitzi [[https://biggsinstitute.org/team-member/mitzi-m-gonzales-ph-d/|Gonzales]] from the Department of Neurology at Uiversity of Texas Health Science Center in San Antinio.\\+Dr. Sudha [[https://www.uthscsa.edu/academics/biomedical-sciences/faculty/profile/53266/Seshadri,-Sudha|Seshadri]], the Founding director of the Glenn [[https://biggsinstitute.org/|Biggs]] Institute for Alzheimer's & Neurodegenerative Diseases, and Dr. Mitzi [[https://biggsinstitute.org/team-member/mitzi-m-gonzales-ph-d/|Gonzales]] from the Department of Neurology at University of Texas Health Science Center in San Antonio. This study is supported by Texas Alzheimer's Research and Care Consortium (TARCC).
  
  
 ===== Analysis ===== ===== Analysis =====
  
-TBD.+  - Linear models. 
 +  - Regularized regression, e.g., the LASSO. 
 +  - Hidden Markov Models (HMM).
  
-===== Analysis ===== 
- 
-TBD. 
  
 ===== Related work ===== ===== Related work =====
  
-  - TBD+  - Eagan, Danielle E., et al. "Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults." Cardiovascular psychiatry and neurology 2012 ([[https://www.hindawi.com/journals/cpn/2012/120540/|2012]]).